News for Healthier Living

Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

February 5, 2025


February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025

February 7 2025

February 6 2025

February 5 2025

February 4 2025

February 3 2025

February 2 2025

February 1 2025

January 31 2025

January 30 2025

January 29 2025